WIN-Partners Co (TSE:3183) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3183 WIN-Partners Co Ltd TSE:3183
58 GF Score
Price 円1,273.00
GF Value 円1,583.30
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is WIN-Partners Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


WIN-Partners Co  (TSE:3183) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


WIN-Partners Co Cyclically Adjusted PB Ratio Related Terms


WIN-Partners Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for WIN-Partners Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WIN-Partners Co Cyclically Adjusted PB Ratio Chart

WIN-Partners Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.58 1.74 1.74 1.71

WIN-Partners Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.80 1.77 1.75 1.78 1.58

TSE:3183 vs MCK, COR, CAH: Cyclically Adjusted PB Ratio Comparison

For the Medical Distribution subindustry, WIN-Partners Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WIN-Partners Co Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's Cyclically Adjusted PB Ratio falls into.


TSE:3183
58GF Score
WIN-Partners Co Ltd TSE:3183
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WIN-Partners Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

WIN-Partners Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, WIN-Partners Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=807.383/113.6000*113.6000
=807.383

Current CPI (Jun. 2026) = 113.6000.

WIN-Partners Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 498.902 98.000 578.319
201612 517.848 98.400 597.841
201703 539.690 98.100 624.962
201706 532.347 98.500 613.956
201709 549.204 98.800 631.473
201712 593.449 99.400 678.227
201803 618.789 99.200 708.613
201806 603.224 99.200 690.789
201809 621.011 99.900 706.175
201812 654.213 99.700 745.422
201903 680.885 99.700 775.813
201906 666.994 99.800 759.224
201909 685.407 100.100 777.845
201912 701.093 100.500 792.479
202003 714.274 100.300 808.988
202006 688.476 99.900 782.892
202009 701.943 99.900 798.205
202012 716.629 99.300 819.829
202103 736.316 99.900 837.292
202106 714.994 99.500 816.315
202109 730.506 100.100 829.026
202112 753.338 100.100 854.937
202203 764.325 101.100 858.826
202206 743.576 101.800 829.767
202209 755.280 103.100 832.200
202212 784.049 104.100 855.600
202303 801.643 104.400 872.286
202306 761.807 105.200 822.636
202309 777.715 106.200 831.906
202312 795.084 106.800 845.707
202403 818.754 107.200 867.635
202406 782.800 108.200 821.868
202409 798.127 108.900 832.573
202412 822.019 110.700 843.553
202503 841.879 111.100 860.823
202506 792.561 111.700 806.042
202509 811.944 112.000 823.543
202512 830.265 113.000 834.673
202603 846.955 112.700 853.719
202606 807.383 113.600 807.383

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is WIN-Partners Co (TSE:3183) Overvalued in 2026?

Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued. The current stock price of 円1,273.00 is trading 19.6% below its estimated GF Value™ of 円1,583.30. GuruFocus considers WIN-Partners Co to be Modestly Undervalued.

Key valuation signals for TSE:3183:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: 円1,583.30 vs. price of 円1,273.00 (19.6% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


WIN-Partners Co Business Description

Address 2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
58GF Score

Get the complete analysis for TSE:3183

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,273.00
Price
円1,583.30
GF Value